We are live on ! Find out more
BCM

Birmingham Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 50.07%
This Fund
S&P 500
This Quarter Est. Return
-1.52%
1 Year Est. Return
+50.07%
3 Year Est. Return
+103.07%
5 Year Est. Return
+134.75%
10 Year Est. Return
+328.27%
AUM
$256M
AUM Growth
-$15.7M
Cap. Flow
-$8.57M
Cap. Flow %
-3.35%
Top 10 Hldgs %
39.2%
Holding
108
New
3
Increased
16
Reduced
50
Closed
4

Top Buys

Rank Stock Value
1
SOLV icon
Solventum
SOLV
+$427K
2
GEV icon
GE Vernova
GEV
+$415K
3
NVDA icon
NVIDIA
NVDA
+$372K
4
JNJ icon
Johnson & Johnson
JNJ
+$245K
5
KHC icon
Kraft Heinz
KHC
+$243K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.6M
2
MMM icon
3M
MMM
+$733K
3
SO icon
Southern Company
SO
+$625K
4
DUK icon
Duke Energy
DUK
+$613K
5
CAT icon
Caterpillar
CAT
+$485K

Sector Composition

Rank Sector Weight
1 Industrials 29.75%
2 Healthcare 16.17%
3 Consumer Staples 11.44%
4 Financials 10.66%
5 Energy 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
1
Caterpillar
CAT
$375B
$16.9M 6.62%
50,865
-1,400
-3% -$485K
DE icon
2
Deere & Co
DE
$168B
$14.5M 5.67%
38,888
-1,200
-3% -$468K
LLY icon
3
Eli Lilly
LLY
$1.11T
$12.6M 4.91%
13,900
-2,005
-13% -$1.6M
MCD icon
4
McDonald's
MCD
$190B
$9.05M 3.53%
35,506
+313
+0.9% +$83K
ALL icon
5
Allstate
ALL
$64.4B
$8.84M 3.45%
55,389
-2,149
-4% -$358K
PG icon
6
Procter & Gamble
PG
$332B
$8.53M 3.33%
51,747
-646
-1% -$106K
CVX icon
7
Chevron
CVX
$404B
$8.43M 3.29%
53,901
-407
-0.7% -$64.9K
EMR icon
8
Emerson Electric
EMR
$86.3B
$7.83M 3.06%
71,061
-3,920
-5% -$433K
LMT icon
9
Lockheed Martin
LMT
$132B
$7.36M 2.87%
15,755
JNJ icon
10
Johnson & Johnson
JNJ
$644B
$6.3M 2.46%
43,076
+1,644
+4% +$245K
XOM icon
11
ExxonMobil
XOM
$683B
$6.16M 2.41%
53,504
-356
-0.7% -$41.5K
IBM icon
12
IBM
IBM
$220B
$5.87M 2.29%
33,958
-179
-0.5% -$31.1K
RTX icon
13
RTX Corp
RTX
$286B
$5.75M 2.25%
57,314
+135
+0.2% +$14K
HSY icon
14
Hershey
HSY
$37.8B
$5.65M 2.2%
30,711
-78
-0.3% -$15.1K
KO icon
15
Coca-Cola
KO
$389B
$5.6M 2.19%
87,934
-900
-1% -$55.7K
CMI icon
16
Cummins
CMI
$81.7B
$5.42M 2.12%
19,560
-800
-4% -$229K
MRK icon
17
Merck
MRK
$368B
$5.11M 2%
41,296
-942
-2% -$121K
ABBV icon
18
AbbVie
ABBV
$463B
$5.1M 1.99%
29,722
PFE icon
19
Pfizer
PFE
$158B
$5.09M 1.99%
181,763
+1,559
+0.9% +$42.9K
AXP icon
20
American Express
AXP
$224B
$4.9M 1.91%
21,160
-1,331
-6% -$308K
MMM icon
21
3M
MMM
$91.8B
$4.24M 1.65%
41,453
-7,515
-15% -$733K
AAPL icon
22
Apple
AAPL
$4.54T
$4.17M 1.63%
19,787
FDX icon
23
FedEx
FDX
$77.2B
$4.06M 1.59%
13,540
-400
-3% -$105K
NVDA icon
24
NVIDIA
NVDA
$5.25T
$4M 1.56%
32,375
+3,675
+13% +$372K
SO icon
25
Southern Company
SO
$105B
$3.99M 1.56%
51,400
-8,250
-14% -$625K

Similar funds

Birmingham Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Birmingham Capital Management held 108 positions worth $256M, down 5.8% from $272M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Birmingham Capital Management withdrew a net $8.57M in Q2 2024, closing 4 positions and reducing 50 holdings. Its most notable exit was Global Payments, an estimated $236K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Birmingham Capital Management opened a new position in Solventum worth $372K.

  • Birmingham Capital Management's largest Q2 2024 buy was Solventum: 7,026 shares worth $372K.
  • Birmingham Capital Management added most to NVIDIA in Q2 2024, an estimated $372K increase.
  • Birmingham Capital Management's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $1.6M.
  • Birmingham Capital Management fully exited Global Payments in Q2 2024, selling an estimated $236K.
  • Birmingham Capital Management's ten largest holdings make up 39% of its $256M portfolio in Q2 2024.
  • Birmingham Capital Management opened 3 new positions and closed 4 in Q2 2024.
  • Birmingham Capital Management's portfolio value fell 5.8% quarter-over-quarter to $256M.

Based on Birmingham Capital Management's 13F filing for Q2 2024, filed 28 Aug 2024.